Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction.
Saved in:
| Title: | Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. |
|---|---|
| Authors: | Lewis GA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., Rosala-Hallas A; Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, England., Dodd S; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Block F, Waterhouse Bld, 1-5 Brownlow Street, Liverpool, L69 3GL, England., Schelbert EB; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, Pittsburgh, PA, USA.; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA., Williams SG; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., Cunnington C; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., McDonagh T; King's College Hospital, Denmark Hill, London, SE5 9RS, UK., Miller CA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England. Christopher.Miller@manchester.ac.uk.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England. Christopher.Miller@manchester.ac.uk.; Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, Wellcome Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester, M13 9PT, England. Christopher.Miller@manchester.ac.uk. |
| Source: | The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2022 Jul; Vol. 38 (7), pp. 1569-1578. Date of Electronic Publication: 2022 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100969716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8312 (Electronic) Linking ISSN: 15695794 NLM ISO Abbreviation: Int J Cardiovasc Imaging Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
